Safe Harbor Financial Advocates for Cannabis Rescheduling: Urges Justice Department to Reclassify from Schedule I to Schedule III
GOLDEN, Colo. July 16, 2024 - SHF Holdings, Inc. operating as Safe Harbor Financial (Safe Harbor or the Company), a renowned provider of banking, payments, and financial services to the regulated cannabis industry, has recently submitted comments to the Justice Department in response to its proposed rule to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). This proposed reclassification aligns with the Department of Health and Human Services’ (HHS) belief that cannabis possesses a currently accepted medical use, as well as their views regarding marijuana’s abuse potential and level of physical or psychological dependence.
Safe Harbor Financial, along with many other industry experts and stakeholders, recognizes the importance of reevaluating the classification of cannabis to reflect its medicinal properties and potential therapeutic benefits. By urging the Justice Department to reschedule cannabis from its current designation as a substance with no accepted medical use, Safe Harbor Financial hopes to pave the way for increased access to medical marijuana for patients in need, while also promoting further research into its potential applications.
The proposed rescheduling to Schedule III would signify that cannabis has accepted medical uses and poses a lesser risk to public health and safety compared to Schedule I drugs like heroin or LSD. Safe Harbor Financial emphasizes that this reclassification would open doors for more comprehensive clinical studies and further advancement in scientific understanding about the therapeutic value and risks associated with cannabis.
The Company’s submission to the Justice Department also emphasizes the existing regulatory framework for cannabis that has been developed in states where medicinal or recreational marijuana is legal. Safe Harbor Financial asserts that by aligning federal schedules with current state laws, the Justice Department can facilitate the operation of legitimate cannabis-related businesses and ensure public safety through effective regulation, taxation, and compliance.
Safe Harbor Financial’s comments to the Justice Department arrive at a crucial juncture, as the proposed rule has garnered significant attention and debate within the medical and cannabis community, law enforcement agencies, and policymakers alike. The Company’s expertise and experience in serving the regulated cannabis industry make their insights integral to shaping sensible drug policies that prioritize patient care, public safety, and economic growth.
In response to Safe Harbor Financial’s submission, industry analysts have observed a downturn in SHF Holdings Inc shares, with the stock currently trading on the NASDAQ at -13.7% below its 52-week average. However, this decline in value appears to reflect investor uncertainty surrounding the future of the cannabis industry, rather than a direct reaction to the Company’s comments.
Comments